tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RVMD Stock Latest News

Revolution Medicines announces first patient dosed in RASolve 301
The FlyRevolution Medicines announces first patient dosed in RASolve 301
24d ago
RVMD
Revolution Medicines price target lowered to $72 from $73 at H.C. Wainwright
PremiumThe Fly
Revolution Medicines price target lowered to $72 from $73 at H.C. Wainwright
24d ago
RVMD
Promising Developments in Revolution Medicines’ RAS(ON) Pipeline for NSCLC Treatment
PremiumRatings
Promising Developments in Revolution Medicines’ RAS(ON) Pipeline for NSCLC Treatment
26d ago
RVMD
Revolution Medicines’ Earnings Call: Optimism Amid Rising Costs
PremiumCompany Announcements
Revolution Medicines’ Earnings Call: Optimism Amid Rising Costs
30d ago
RVMD
Revolution Medicines price target lowered to $80 from $87 at Guggenheim
PremiumThe Fly
Revolution Medicines price target lowered to $80 from $87 at Guggenheim
1M ago
RVMD
Revolution Medicines price target raised to $75 from $70 at Oppenheimer
PremiumThe FlyRevolution Medicines price target raised to $75 from $70 at Oppenheimer
1M ago
RVMD
Revolution Medicines: Strategic Advancements in NSCLC Treatment Drive Buy Rating
Premium
Ratings
Revolution Medicines: Strategic Advancements in NSCLC Treatment Drive Buy Rating
1M ago
RVMD
Revolution Medicines’ Promising RAS+ NSCLC Market Position and Drug Efficacy Justify Buy Rating
Premium
Ratings
Revolution Medicines’ Promising RAS+ NSCLC Market Position and Drug Efficacy Justify Buy Rating
1M ago
RVMD
Buy Recommendation for Revolution Medicines: Promising RAS(ON) Platform and Strong Financial Position
PremiumRatings
Buy Recommendation for Revolution Medicines: Promising RAS(ON) Platform and Strong Financial Position
1M ago
RVMD
Revolution Medicines Reports Q1 2025 Financial Results
PremiumCompany Announcements
Revolution Medicines Reports Q1 2025 Financial Results
1M ago
RVMD
Closing Bell Movers: Arm sinks over 10% as guidance falls short
PremiumThe Fly
Closing Bell Movers: Arm sinks over 10% as guidance falls short
1M ago
G
Z
Revolution Medicines reports Q1 EPS ($1.13), consensus ($1.06)
PremiumThe Fly
Revolution Medicines reports Q1 EPS ($1.13), consensus ($1.06)
1M ago
RVMD
Positive Clinical Data and Competitive Efficacy Drive Buy Rating for Revolution Medicines’ Zoldonrasib
PremiumRatingsPositive Clinical Data and Competitive Efficacy Drive Buy Rating for Revolution Medicines’ Zoldonrasib
1M ago
RVMD
Revolution Medicines shares up 6% after presenting initial RMC-9805 study data
Premium
The Fly
Revolution Medicines shares up 6% after presenting initial RMC-9805 study data
1M ago
RVMD
Promising Phase 1 Results for Revolution Medicines’ Zoldonrasib in NSCLC Support Buy Rating
Premium
Ratings
Promising Phase 1 Results for Revolution Medicines’ Zoldonrasib in NSCLC Support Buy Rating
1M ago
RVMD
Revolution Medicines: Promising Phase 3 Progress and Strong RAS-ON Platform Drive Buy Rating
PremiumRatings
Revolution Medicines: Promising Phase 3 Progress and Strong RAS-ON Platform Drive Buy Rating
2M ago
RVMD
Revolution Medicines price target lowered to $64 from $78 at Stifel
PremiumThe Fly
Revolution Medicines price target lowered to $64 from $78 at Stifel
2M ago
RVMD
Erasca initiated with an Outperform at Raymond James
PremiumThe Fly
Erasca initiated with an Outperform at Raymond James
2M ago
ERAS
RVMD
Revolution Medicines price target raised to $73 from $72 at H.C. Wainwright
PremiumThe Fly
Revolution Medicines price target raised to $73 from $72 at H.C. Wainwright
3M ago
RVMD
Revolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs
PremiumCompany AnnouncementsRevolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs
3M ago
RVMD
Revolution Medicines Reports 2024 Financial Results and Progress
Premium
Company Announcements
Revolution Medicines Reports 2024 Financial Results and Progress
3M ago
RVMD
Revolution Medicines reports Q4 EPS ($1.12), consensus (96c)
Premium
The Fly
Revolution Medicines reports Q4 EPS ($1.12), consensus (96c)
3M ago
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >